arrow
M

Maria Creignou

national precision medicine center in oncology
H指数:13
被引数:1,792

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

骨髓增生异常肿瘤中环状RNA表达景观:与突变特征和疾病进展的关联

2026-02-010
OAAI
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

Alnuctamab,一种靶向B细胞成熟抗原的双价T细胞结合剂,用于复发或难治性多发性骨髓瘤患者:一项1期首次人体研究的成果

Leukemia
IF13.4
2026-01-070
OAAI
Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia—A population-based study

合并症和突变,包括单次和多次打击的TET2突变,与慢性骨髓单核细胞白血病预后的关系——一项基于人群的研究

2025-11-250
OAAI
FROM RNA TO PROTEIN (OR NOT)-RNA SPLICING FACTOR MUTATIONS REWIRE THE HEMATOPOIETIC PROTEOME

从RNA到蛋白质(或不)-RNA剪接因子突变重编程造血蛋白质组

2025-09-010
OAAI
Imaging of CCR9 in the small bowel of patients with Crohn's disease: effects of the CCR9-depleting monoclonal antibody AZD7798
2025-01-220
PRE
Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10)
LEUKEMIA
IF13.4
2024-12-230
OAAI
Large-Scale Transcriptome Analysis Supports Genomic Taxonomy and Predicts Response to Hypomethylating Agents in Myelodysplastic Neoplasms

大规模转录组分析支持基因组分类,并预测骨髓增生异常新生物对去甲基化药物的反应

BLOOD
IF23.1
2024-11-050
PRE
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms

如何管理种系DDX41变异患者: 来自骨髓肿瘤种系易感性北欧工作组的建议

2024-08-130
OAAI
Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
2024-04-230
OAAI
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts
2023-11-032
OAAI
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts
2023-07-271
OAAI
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
2023-07-1716
OAAI
Implementation and adoption of a web tool to support precision diagnostic and treatment decisions for patient with myelodysplastic syndromes

实施和采用网络工具以支持骨髓增生异常综合征患者的精确诊断和治疗决策

2023-04-040
PRE
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population
2021-12-018
OAAI
ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing
2021-07-1423
OA
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (vol 26, pg 1549, 2020)

TP53等位基因状态对骨髓增生异常综合征基因组稳定性、临床表现和预后的影响 (第26卷,1549页,2020)

2021-05-045
OAAI
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (vol 26, pg 1549, 2020)

TP53等位基因状态对骨髓增生异常综合征基因组稳定性、临床表现和预后的影响 (第26卷,1549页,2020)

2021-02-092
OAAI